Related Experiment Videos
[Anomalies of the immune system in chronic inflammatory bowel diseases]
S Jacquot1, L Boumsell, A Bensussan
1INSERM Unité 93, Hôpital Saint-Louis, Paris.
Gastroenterologie Clinique Et Biologique
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
In vitro effects of wound-dressings on key wound healing properties of dermal fibroblasts.
Experimental dermatology·2024
The value of five blood markers in differentiating mycosis fungoides and Sézary syndrome: a validation cohort.
The British journal of dermatology·2020
Revisiting the initial diagnosis and blood staging of mycosis fungoides and Sézary syndrome with the KIR3DL2 marker.
The British journal of dermatology·2019
Cutaneous presentation of adult T-cell leukemia/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016.
Annales de dermatologie et de venereologie·2018
Study of gene expression alteration in male androgenetic alopecia: evidence of predominant molecular signalling pathways.
The British journal of dermatology·2017
[Treatment of chronic hepatitis B: adherence and safety].
Gastroenterologie clinique et biologique·2010
[Long-term therapy for chronic hepatitis B in HIV co-infected patients].
Gastroenterologie clinique et biologique·2010
[Analogs combination therapy in chronic hepatitis B: when and how?].
Gastroenterologie clinique et biologique·2010
[HBsAg seroclearance: prognostic value for the response to treatment and the long-term outcome].
Gastroenterologie clinique et biologique·2010
[HBsAg quantification: virological significance].
Gastroenterologie clinique et biologique·2010
[Influence of treatment on long-term evolution of chronic hepatitis B].
Gastroenterologie clinique et biologique·2010
Treatment patterns, access, and multidimensional burden of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in China: A nationwide cross-sectional study.
Therapeutic advances in neurological disorders·2026
Efficacy and safety of interleukin-6 receptor inhibitors in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review and meta-analysis.
Therapeutic advances in neurological disorders·2026